Skip to navigation Skip to content


In-person CE Opportunities:

PreviousMarch 2019Next
  1. No events found.

Online CE Opportunities:

  1. Adaptive Driving Modifications

    The National Mobility Equipment Dealers Association (NMEDA) is offering two FREE introductory level online CE courses to help healthcare professionals understand automotive mobility options and solutions for patients with disabilities.

  2. Advances in MS Research and Practice

    This CNE program showcases leading experts sharing clinical experience and offering valuable updates and strategies to meet the challenges that MS nurses are undertaking as clinicians, educators, and advocates for their patients

  3. Advances in MS Research and Practice (for Nurses)

  4. Advances in Psychotherapy – Evidence-Based Practice

    Practical, evidence-based guidance on diagnosis and treatment for the most common disorders seen in clinical practice – written in a uniquely reader-friendly manner.

  5. Biomarkers, Treatments, and Comorbidities: Translating Data to Clinical Practice When Managing Patients with Multiple Sclerosis

    This video is a replay of a plenary session from the 9th Annual Chair Summit Master Class for Neuroscience Professional Development held in Miami, Florida on September 15 – 17, 2016.

  6. Case Study in MS: Managing a Patient with Relapsing-Remitting Multiple Sclerosis and Suboptimal Response to Two Prior Therapies

    This case in the Multiple Sclerosis @Point of Care program reviews the real-life case scenario of a patient with relapsing-remitting multiple sclerosis that has been treated with two prior lines of therapy and now requires a switch in therapy due to suboptimal response. Guidance, strategies, and relevant efficacy and safety data will be reviewed. (CME expiration date: January 28, 2020)

  7. Case Study in Multiple Sclerosis: New Approach to Managing a Patient with Primary-Progressive Multiple Sclerosis

    This case in the Multiple Sclerosis @Point of Care program illustrates the real-life clinical scenario of a patient with primary-progressive multiple sclerosis (PPMS) and the recommended steps for diagnosis and initial treatment of this disease. Throughout this case, the recommended diagnostic and treatment strategies for patients with PPMS will be discussed.

  8. Considerations for Improving Multiple Sclerosis Treatment and Engagement in the African American Population

    This case-based enduring activity will cover the treatment and management of patients with multiple sclerosis (MS). Intended Audience This activity is designed to meet the needs of neurologists, nurses, nurse practitioners, and other healthcare professionals treating patients with MS.

  9. Current Topics- Diagnosis of Multiple Sclerosis in 2019: Current Best Practice and Future Directions

  10. Current Topics- MS in the African American Population

  11. Current Topics- Recognizing and Managing Depression in your Patients

  12. Determining Active RRMS Using MRIs With Consideration of Aggressive Treatment Options And Clinical Trials

    The goal of this CME/CE activity is to provide state-of-the-science discussions of the MRI as a tool in measuring disease activity, disease progression, response to therapy, and practical therapeutic approaches that improve outcomes of patients with MS.

  13. Diet Quality is Associated with Disability and Symptom Severity in MS

    Upon completion of the article by Fitzgerald et al, the participant should be able to: • Identify patient-level factors among patients with multiple sclerosis (MS) in this study that are associated with higher diet quality scores • Describe the association between dietary quality and MS-related disability observed in this study • List individual dietary components for which higher intake was associated with lower rates of disability in this study

  14. ECTRIMS 2016: Optimally Managing Patients With Multiple Sclerosis Through Individualized Treatment Options

  15. Emerging Agents for Advanced MS

    Speakers: Edward J. Fox, MD, PhD, Clinical Associate Professor of Neurology, Lori Mayer, DNP, MSCN, Director, Medical Research, Jerry S. Wolinsky, MD, Emeritus Professor in Neurology. Jointly provided by Consortium of Multiple Sclerosis Centers and PlatformQ Health Education, LLC.

  16. Epstein-Barr Virus, Cytomegalovirus, And Multiple Sclerosis Susceptibility: A Multiethnic Study

    This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

  17. Expert Debates in Multiple Sclerosis: Opposing Views in Management: Module 4. Pregnancy-Related Treatment Considerations in Multiple Sclerosis

    Learning Objectives After completing this activity, the participant should be better able to: • Review and understand the most current evidence related to treatment approaches for MS patients who become pregnant or plan to become pregnant

  18. Expert Perspectives on New Data in MS From the 2018 Annual Neurology Meeting

    The goal of this activity is to educate physicians on novel data from the latest clinical trials including key biomarkers, recognition, and assessment strategies in order to optimally manage patients with multiple sclerosis (MS).

  19. From Novice to Expert: A Series in Multiple Sclerosis Management

    Target Audience: Neurologists, internists, family physicians, primary care clinicians, physician assistants, nurse practitioners, nurses, and pharmacists involved in the care of patients with MS. This session has been approved for 3.0 AMA PRA Category 1 Credit™. The enduring material will be available from April 5, 2018 to April 5, 2019.

  20. Implementing new treatment strategies in MS

    The program covers newer treatment strategies in MS, how they work, and how to implement them into clinical practice. This six- module e-learning course includes content from the UEMS/EACCME-accredited meeting “Integrating Innovations in the Treatment of Multiple Sclerosis into Clinical Practice” to enhance the interactive online learning modules.

  21. Innovations in Managing Immune Dysfunction in Patients with Multiple Sclerosis

    This on-demand webinar provides expert insight into the role of immune dysfunction in MS, the current treatment landscape for MS patients, and the possibility of using pulsed immune reconstitution therapy (PIRT) treatments to induce drug-free remission in MS patients.

  22. Intro to MS for Fitness and Wellness Professionals

    Free online training course for fitness and wellness professionals, including aquatics instructors, yoga teachers, personal trainers, and others who want to learn more about MS. The course provides an overview of the disease and offers specific strategies for working with a diverse MS population. This online course has been approved by the American Council on Exercise.

  23. Key Topics in MS from Recent Meetings: An Audio Webcast

    Many scientific advances have been made in both the diagnosis and treatment of multiple sclerosis (MS) in recent years. Join Anne Cross, MD, and panelists James Bowen, MD, and John Rinker, MD, as they discuss exciting topics presented at the 2017 ECTRIMS-ACTRIMS and Society for Neuroscience meetings.

  24. MS in 2018: Highly Complex, Yet More Personal Than Ever - The Science of MS Management

    Mayo Clinic neurologist Brian Weinshenker, MD, emphasizes that treatment of MS is not one-size-fits-all.

  25. Multiple Sclerosis: New Options for Care

    Nurse CE course

  26. Pressing Issues in Progressive MS: Experts Convene

    Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative disorder of the central nervous system that represents the most common cause of nontraumatic neurological disability in young adults. Approximately 10% to 15% of patients with MS have primary progressive MS (PPMS), which, from onset, involves unremitting disease progression, without distinct relapses.

  27. Treatment of a Relapsing Multiple Sclerosis Patient Requiring a Therapy Switch

    Patients with relapsing multiple sclerosis can have breakthrough disease activity despite compliance with therapy, which requires consideration of a treatment switch. This case demonstrates the real-life clinical scenario of a woman with clinically active disease despite compliance with interferon beta therapy, with a discussion of alternative disease-modifying therapies that includes efficacy, safety, and the importance of patient preference. (CME expiration date: February 4, 2020)